ZVSA

ZyVersa Therapeutics

Delisted

ZVSA was delisted on the 16th of July, 2025.

7 hedge funds and large institutions have $84.9K invested in ZyVersa Therapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
TSS
1
Two Sigma Securities
New York
$23.4K +$9.4K +1,254 +67%
CSS
2
Cubist Systematic Strategies
Connecticut
$22K +$22K +2,937 New
UBS Group
3
UBS Group
Switzerland
$14.9K +$12.5K +1,664 +509%
Jane Street
4
Jane Street
New York
$9.09K +$9.09K +1,212 New
HF
5
HRT Financial
New York
$9K +$9K +1,318 New
TRCT
6
Tower Research Capital (TRC)
New York
$6.41K +$3.42K +456 +115%
Wells Fargo
7
Wells Fargo
California
$9
JPMorgan Chase & Co
8
JPMorgan Chase & Co
New York
$1
AFM
9
Anson Funds Management
Texas
-$145K -16,067 Closed
Citadel Advisors
10
Citadel Advisors
Florida
-$13.5K -1,499 Closed